Related Experiment Video

Updated: Aug 6, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

793

Myocardial Surgical Revascularization in Patients with Reduced Left Ventricular Ejection Fraction

Nedzad Kadric1, Enes Osmanovic2, Sevleta Avdic2

  • 1Department of General Surgery. Medical Institute Bayer, Tuzla, Bosnia and Herzegovina.

Medical Archives (Sarajevo, Bosnia and Herzegovina)
|March 20, 2023
PubMed

Insights

Coronary artery bypass grafting (CABG) is beneficial for patients with multivessel coronary disease, improving left ventricular function and long-term survival. Careful consideration of surgical techniques is needed to minimize complications in patients with low ejection fraction.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Interventional Cardiology

Background:

  • Myocardial surgical revascularization in patients with low left ventricular ejection fraction (LVEF) is associated with significant morbidity and mortality.
  • Identifying and mitigating perioperative and postoperative complications is crucial for improving outcomes.

Purpose of the Study:

  • To investigate and eliminate the reasons for common perioperative and postoperative complications in patients undergoing myocardial revascularization.
  • To compare outcomes between conventional CABG with cardiopulmonary bypass (cCABG-CPB) and off-pump CABG (OPCAB).

Main Methods:

  • Analysis of 64 patients who underwent coronary artery bypass grafting (CABG) in 2019.
  • Patients were divided into cCABG-CPB and OPCAB groups.
  • Evaluation of patient demographics, medical history (including previous myocardial infarction), and coronary artery disease severity.

Main Results:

  • The incidence of postoperative complications was significantly higher in the cCABG-CPB group compared to the OPCAB group (p=0.030).
  • Patients with critical stenosis of the left main coronary artery and prior myocardial infarction were included in the study.
  • The study included 16 women and 48 men, with an average age of 61.29 years.

Conclusions:

  • Myocardial revascularization is justified, particularly for multivessel coronary disease.
  • The procedure significantly improves left ventricular systolic function in the long term.
  • Improved cardiac function leads to enhanced quality and length of life.
Abstract

Keywords:
Myocardial Surgical RevascularizationReduced Left Ventricular Ejection Fraction

More Related Videos

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.3K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.5K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
21
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
20
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
22